BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11925908)

  • 21. The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis.
    Wernicke D; Seyfert C; Gromnica-Ihle E; Stiehl P
    Autoimmunity; 2006 Jun; 39(4):307-13. PubMed ID: 16891219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamics of interleukin (IL)-18 in serum, synovial fluid and synovial membrane in the patients with rheumatoid arthritis].
    Munakata T; Uzuki M; Shimamura T; Sawai T
    Ryumachi; 2001 Jun; 41(3):625-34. PubMed ID: 11505512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J
    Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
    Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
    Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.
    Iwaki-Egawa S; WatanabeY ; Matsuno H
    J Rheumatol; 2001 Mar; 28(3):485-9. PubMed ID: 11296946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of metalloproteinases in fifty joint fluid specimens.
    Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
    Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction.
    Uchibori M; Nishida Y; Tabata I; Sugiura H; Nakashima H; Yamada Y; Ishiguro N
    J Rheumatol; 2004 Jan; 31(1):110-9. PubMed ID: 14705229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.
    Wernicke D; Schulze-Westhoff C; Bräuer R; Petrow P; Zacher J; Gay S; Gromnica-Ihle E
    Arthritis Rheum; 2002 Jan; 46(1):64-74. PubMed ID: 11817610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type IV collagen alpha-chain composition in synovial lining from trauma patients and patients with rheumatoid arthritis.
    Poduval P; Sillat T; Beklen A; Kouri VP; Virtanen I; Konttinen YT
    Arthritis Rheum; 2007 Dec; 56(12):3959-67. PubMed ID: 18050191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
    Xue M; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2007 Sep; 56(9):2864-74. PubMed ID: 17763449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells.
    Sun HB; Nalim R; Yokota H
    Connect Tissue Res; 2003; 44(1):42-9. PubMed ID: 12945803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.